Kyung Dong Pharmaceutical Co. Ltd (011040) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.021x

Based on the latest financial reports, Kyung Dong Pharmaceutical Co. Ltd (011040) has a cash flow conversion efficiency ratio of 0.021x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.75 Billion ≈ $3.22 Million USD) by net assets (₩231.58 Billion ≈ $156.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Kyung Dong Pharmaceutical Co. Ltd market capitalisation for the company's overall valuation and market capitalisation.

Kyung Dong Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Kyung Dong Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kyung Dong Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kyung Dong Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency. Explore 011040 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Vizsla Copper Corp V:VCU	-0.037x
Air T Inc NASDAQ:AIRT	-0.034x
Outcrop Gold Corp V:OCG	-0.200x
Canterbury Park Holding Corporation NASDAQ:CPHC	0.048x
Big Sky Industrial Inc. NASDAQ:BSIN	-0.022x
Inoue Rubber (Thailand) Public Company Limited BK:IRC	0.037x
Vbt Yazilim AS IS:VBTYZ	-0.057x
Panram International TWO:8088	-0.051x

Annual Cash Flow Conversion Efficiency for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025. View Kyung Dong Pharmaceutical Co. Ltd (011040) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩228.87 Billion ≈ $155.10 Million	₩16.93 Billion ≈ $11.48 Million	0.074x	+301.66%
2024-12-31	₩220.06 Billion ≈ $149.13 Million	₩-8.07 Billion ≈ $-5.47 Million	-0.037x	-26148.62%
2023-12-31	₩228.48 Billion ≈ $154.84 Million	₩-31.94 Million ≈ $-21.64K	0.000x	+96.66%
2022-12-31	₩257.20 Billion ≈ $174.30 Million	₩-1.07 Billion ≈ $-728.49K	-0.004x	-108.74%
2021-12-31	₩259.82 Billion ≈ $176.08 Million	₩12.42 Billion ≈ $8.42 Million	0.048x	-26.76%
2020-12-31	₩262.19 Billion ≈ $177.68 Million	₩17.12 Billion ≈ $11.60 Million	0.065x	+632.25%
2019-12-31	₩226.71 Billion ≈ $153.64 Million	₩-2.78 Billion ≈ $-1.88 Million	-0.012x	-107.81%
2018-12-31	₩211.72 Billion ≈ $143.48 Million	₩33.27 Billion ≈ $22.55 Million	0.157x	+134.79%
2017-12-31	₩220.95 Billion ≈ $149.74 Million	₩14.79 Billion ≈ $10.02 Million	0.067x	-45.18%
2016-12-31	₩209.93 Billion ≈ $142.26 Million	₩25.63 Billion ≈ $17.37 Million	0.122x	+37.17%
2015-12-31	₩205.14 Billion ≈ $139.02 Million	₩18.26 Billion ≈ $12.37 Million	0.089x	-25.43%
2014-12-31	₩190.43 Billion ≈ $129.05 Million	₩22.73 Billion ≈ $15.40 Million	0.119x	+22.85%
2013-12-31	₩169.03 Billion ≈ $114.55 Million	₩16.42 Billion ≈ $11.13 Million	0.097x	-25.16%
2012-12-31	₩153.76 Billion ≈ $104.20 Million	₩19.96 Billion ≈ $13.53 Million	0.130x	-25.02%
2011-12-31	₩150.62 Billion ≈ $102.07 Million	₩26.08 Billion ≈ $17.67 Million	0.173x	--

About Kyung Dong Pharmaceutical Co. Ltd

KQ:011040 Korea Pharmaceuticals

Market Cap

$80.33 Million

₩118.53 Billion KRW

Market Cap Rank

#20137 Global

#1067 in Korea

Share Price

₩5040.00

Change (1 day)

+0.00%

52-Week Range

₩4720.00 - ₩6160.00

All Time High

₩14206.86